394 related articles for article (PubMed ID: 25931291)
1. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.
Parikh SA; Leis JF; Chaffee KG; Call TG; Hanson CA; Ding W; Chanan-Khan AA; Bowen D; Conte M; Schwager S; Slager SL; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD
Cancer; 2015 Sep; 121(17):2883-91. PubMed ID: 25931291
[TBL] [Abstract][Full Text] [Related]
2. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia is a predictor of early death.
Andersen MA; Vojdeman FJ; Andersen MK; Brown Pde N; Geisler CH; Weis Bjerrum O; Niemann CU
Leuk Lymphoma; 2016 Jul; 57(7):1592-9. PubMed ID: 26850493
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.
Svensson T; Höglund M; Cherif H
Scand J Infect Dis; 2013 Jul; 45(7):537-42. PubMed ID: 23427875
[TBL] [Abstract][Full Text] [Related]
4. IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia.
Ishdorj G; Streu E; Lambert P; Dhaliwal HS; Mahmud SM; Gibson SB; Banerji V; Marshall AJ; Johnston JB
Blood Adv; 2019 Jul; 3(14):2188-2198. PubMed ID: 31324639
[TBL] [Abstract][Full Text] [Related]
5. Does increasing immunoglobulin levels impact survival in solid organ transplant recipients with hypogammaglobulinemia?
Florescu DF; Kalil AC; Qiu F; Grant W; Morris MC; Schmidt CM; Florescu MC; Poole JA
Clin Transplant; 2014 Nov; 28(11):1249-55. PubMed ID: 25203509
[TBL] [Abstract][Full Text] [Related]
6. Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
Lech-Maranda E; Grzybowska-Izydorczyk O; Wyka K; Mlynarski W; Borowiec M; Antosik K; Cebula-Obrzut B; Makuch-Lasica H; Nowak G; Klimkiewicz-Wojciechowska G; Wawrzyniak E; Bilinski P; Robak T; Warzocha K
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):477-86. PubMed ID: 22945689
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study Group.
Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Ruchlemer R; Berrebi A; Polliack A;
Eur J Haematol; 2014 Jul; 93(1):29-33. PubMed ID: 24547751
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia.
Mauro FR; Morabito F; Vincelli ID; Petrucci L; Campanelli M; Salaroli A; Uccello G; Petrungaro A; Ronco F; Raponi S; Nanni M; Neri A; Ferrarini M; Guarini AR; Foà R; Gentile M
Leuk Res; 2017 Jun; 57():65-71. PubMed ID: 28292720
[TBL] [Abstract][Full Text] [Related]
9. Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.
Hampel PJ; Chaffee KG; King RL; Simonetto D; Larson MC; Achenbach S; Call TG; Ding W; Kenderian SS; Leis JF; Chanan-Khan AA; Bowen DA; Conte MJ; Schwager SM; Hanson CA; Slager SL; Kay NE; Shanafelt TD; Parikh SA
Am J Hematol; 2017 Dec; 92(12):1362-1369. PubMed ID: 28940587
[TBL] [Abstract][Full Text] [Related]
10. IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.
Fang H; Reichard KK; Rabe KG; Hanson CA; Call TG; Ding W; Kenderian SS; Muchtar E; Schwager SM; Leis JF; Chanan-Khan AA; Slager SL; Braggio E; Smoley SA; Kay NE; Shanafelt TD; Van Dyke DL; Parikh SA
Am J Hematol; 2019 Mar; 94(3):338-345. PubMed ID: 30575108
[TBL] [Abstract][Full Text] [Related]
11. The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL.
Parikh SA; Rabe KG; Kay NE; Call TG; Ding W; Leis JF; Kenderian SS; Muchtar E; Wang Y; Koehler AB; Schwager SM; Lesnick CE; Kleinstern G; Van Dyke D; Hanson CA; Braggio E; Slager SL; Shanafelt TD
Blood; 2021 Jul; 138(2):149-159. PubMed ID: 33876228
[TBL] [Abstract][Full Text] [Related]
12. Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Shanafelt TD; Kay NE; Rabe KG; Inwards DJ; Zent CS; Leis JF; Schwager SM; Thompson CA; Bowen DA; Witzig TE; Slager SL; Call TG
Cancer; 2012 Apr; 118(7):1827-37. PubMed ID: 22009554
[TBL] [Abstract][Full Text] [Related]
13. IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia.
Reda G; Cassin R; Gentile M; Mauro FR; Giannarelli D; Fattizzo B; Barbieri M; Silvestris I; Fabris S; Morabito F; Neri A; Barcellini W; Cortelezzi A
Leukemia; 2019 Jun; 33(6):1519-1522. PubMed ID: 30635629
[No Abstract] [Full Text] [Related]
14. Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients.
Meuleman N; Stamatopoulos B; Dejeneffe M; El Housni H; Lagneaux L; Bron D
Leukemia; 2008 Oct; 22(10):1882-90. PubMed ID: 18633433
[TBL] [Abstract][Full Text] [Related]
15. Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia.
Sun Q; Wang L; Zhu HY; Miao Y; Wu W; Liang JH; Cao L; Xia Y; Wu JZ; Wang Y; Wang R; Fan L; Xu W; Li JY
Chin Med J (Engl); 2019 Mar; 132(5):525-533. PubMed ID: 30741830
[TBL] [Abstract][Full Text] [Related]
16. The clinical course of lung carcinoma in patients with chronic lymphocytic leukemia.
Parekh K; Rusch V; Kris M
Cancer; 1999 Nov; 86(9):1720-3. PubMed ID: 10547544
[TBL] [Abstract][Full Text] [Related]
17. A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia.
Tecchio C; Nichele I; Mosna F; Zampieri F; Leso A; Al-Khaffaf A; Veneri D; Andreini A; Pizzolo G; Ambrosetti A
Eur J Haematol; 2011 Sep; 87(3):228-34. PubMed ID: 21595749
[TBL] [Abstract][Full Text] [Related]
18. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul.
Pamuk ON; Pamuk GE; Soysal T; Ongören S; Başlar Z; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
South Med J; 2004 Mar; 97(3):240-5. PubMed ID: 15043330
[TBL] [Abstract][Full Text] [Related]
20. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80 years or more. An ICLLSG study.
Bairey O; Ruchlemer R; Rahimi-Levene N; Herishanu Y; Braester A; Berrebi A; Polliack A; Klepfish A; Shvidel L;
Ann Hematol; 2011 Oct; 90(10):1123-9. PubMed ID: 21614458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
